Cargando…
Evaluation of liver function in symptomatic COVID-19 patients
CONTEXT: The coronavirus disease 2019 (COVID-19) is a viral respiratory illness which was first detected in Wuhan, Hubei Province, China. A few case studies demonstrated that 14–53% of the cases of COVID-19 reported abnormal levels of liver enzymes during disease progression. Patients with severe CO...
Autores principales: | Singhai, Abhishek, Pavan, G. Sai, Panda, Smritimayee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565151/ https://www.ncbi.nlm.nih.gov/pubmed/34760739 http://dx.doi.org/10.4103/jfmpc.jfmpc_2527_20 |
Ejemplares similares
-
Small Thyroid Nodule but Big Impact
por: Singhai, Abhishek, et al.
Publicado: (2020) -
Comparison of standard dose with high dose of methylprednisolone in the management of COVID-19 patients admitted in ICU
por: Singhai, Abhishek, et al.
Publicado: (2021) -
Evaluation of preoperative liver function test efficacy in patients with symptomatic cholelithiasis
por: Rezaei Tavirani, Majid, et al.
Publicado: (2020) -
Guillain–Barre Syndrome following SARS-COVID-19 Infection: A Case Report from India
por: Singhai, Abhishek, et al.
Publicado: (2021) -
Relapse in bipolar disorder in hospitalized patients with COVID-19: A case series and key recommendations
por: Panda, Tushar Kanta, et al.
Publicado: (2021)